Department of Energy, Institute for Genomics and Proteomics, University of California, Los Angeles, CA 90095.
Department of Chemistry and Biochemistry, University of California, Los Angeles, CA 90095.
Proc Natl Acad Sci U S A. 2023 Sep 12;120(37):e2305494120. doi: 10.1073/pnas.2305494120. Epub 2023 Sep 5.
Cryoelectron microscopy (Cryo-EM) has enabled structural determination of proteins larger than about 50 kDa, including many intractable by any other method, but it has largely failed for smaller proteins. Here, we obtain structures of small proteins by binding them to a rigid molecular scaffold based on a designed protein cage, revealing atomic details at resolutions reaching 2.9 Å. We apply this system to the key cancer signaling protein KRAS (19 kDa in size), obtaining four structures of oncogenic mutational variants by cryo-EM. Importantly, a structure for the key G12C mutant bound to an inhibitor drug (AMG510) reveals significant conformational differences compared to prior data in the crystalline state. The findings highlight the promise of cryo-EM scaffolds for advancing the design of drug molecules against small therapeutic protein targets in cancer and other human diseases.
冷冻电子显微镜(Cryo-EM)能够解析大小超过约 50 kDa 的蛋白质结构,包括许多用其他方法难以解决的蛋白质,但对于较小的蛋白质,它在很大程度上失败了。在这里,我们通过将它们与基于设计的蛋白质笼的刚性分子支架结合,获得了小分子蛋白质的结构,分辨率达到 2.9 Å,揭示了原子细节。我们将该系统应用于关键的癌症信号蛋白 KRAS(大小为 19 kDa),通过 cryo-EM 获得了四个致癌突变变体的结构。重要的是,与晶体状态下先前的数据相比,与抑制剂药物(AMG510)结合的关键 G12C 突变体的结构显示出显著的构象差异。这些发现突显了 cryo-EM 支架在推进针对癌症和其他人类疾病中小治疗蛋白靶标的药物分子设计方面的前景。